Form 8-K RIGEL PHARMACEUTICALS For: Jan 22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Rigel Pharmaceuticals (RIGL) PT Raised to $11 at BMO Capital
January 23, 2019 1:15 PM ESTBMO Capital analyst Do Kim raised the price target on Rigel Pharmaceuticals (NASDAQ: RIGL) to $11.00 (from $10.00) while maintaining a Outperform rating.
Kim commented, "We believe the signing of a European partner represents an important milestone, as it provides non-dilutive financing as well as additional... More
